Drugs / rBV A/B
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06112834 | Jul 2024 → Jun 2025 | botulism | California Department of Public Health | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rBV A/B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06112834 ↗ |
| Known as | Recombinant Botulinum Vaccine A/B | “Recombinant Botulinum Vaccine A/B, rBV A/B” NCT06112834 ↗ |